August 4, 2017 — The U.S. Judicial Panel on Multidistrict Litigation (JPML) has centralized 161 lawsuits involving kidney injuries from heartburn drugs like Nexium and Prilosec into one federal court.
The lawsuits will be coordinated in Multi-District Litigation (MDL No. 2798) under Judge Claire C. Cecchi in the District of New Jersey — In RE: Proton-Pump Inhibitor Products Liability Litigation (No. II).
Drug-makers are accused of failing to adequately warn that PPI heartburn drugs can cause kidney injuries, Chronic Kidney Disease (CKD), acute interstitial nephritis, end-stage kidney disease, or kidney failure.
The JPML rejected centralizing the lawsuits in January 2017 because the lawsuits involved so many different drugs and different types of injuries. The JPML reconsidered after AstraZeneca and Pfizer said they would support centralization because there were so many cases.
The PPI class of heartburn medications includes:
- Aciphex (rabeprazole)
- Dexilant (dexlansoprazole)
- Nexium (esomeprazole)
- Prevacid (lansoprazole)
- Prilosec (omeprazole)
- Protonix (pantoprazole)
- Vimovo (naproxen / esomeprazole)
- Zegerid (omeprazole / sodium bicarbonate)
Do I have a Nexium Lawsuit?
The Schmidt Firm, PLLC is currently accepting Nexium induced injury cases in all 50 states. If you or somebody you know has been diagnosed with kidney damage, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.